CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CALC is expected to report earnings to rise 39.39% to -46 cents per share on May 10
Q1'23
Est.
$-0.46
Q4'24
Beat
by $0.65
Q4'22
Beat
by $0.08
Q3'22
Missed
by $0.05
Q2'22
Beat
by $0.02
The last earnings report on March 27 showed earnings per share of -33 cents, beating the estimate of -98 cents. With 2.92K shares outstanding, the current market capitalization sits at 20.22M.